Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis

Abstract CKD progression depends on the activation of an intricate set of hemodynamic and inflammatory mechanisms, promoting renal leukocyte infiltration, inflammation and fibrosis, leading to renal function loss. There are currently no specific drugs to detain renal fibrogenesis, which is a common...

Full description

Bibliographic Details
Main Authors: Camilla Fanelli, Ana L. R. Francini, Giovanna A. Celestrino, Flávio Teles, Ana P. Barbosa, Paloma Noda, Leandro R. Iannuzzi, Cristiane R. Guzzo, Felipe M. Ornellas, Irene L. Noronha
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39299-9